Patent US4234726A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4234726A Expired / Lapsed US ⏱️ 0.0 years remaining

Heterocyclic containing chromans

Assignee: Beecham Group PLC
•
Filing: 1979-05-09
•
Granted: 1980-11-18
•
Expires: 1999-05-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula (I): ##STR1## or a pharmaceutically acceptable salt thereof wherein the NR 1 R 2 moiety is a 5-, 6-, or 7-membered saturated heterocyclic ring; R 3 is hydrogen, alkyl of 1 to 4 carbon atoms or acyl of 1 to 4 carbon atoms; R 4 is naphthyl or phenyl unsubstituted or substituted by one or two substituents selected from the group consisting of fluorine, chlorine, bromine, methoxyl, benzyloxyl, trifluoromethyl, methyl, cyano, nitro, acetoxyl, amino, methylamino, ethylamino, dimethylamino, diethylamino, acetamide, hydroxyl, methoxycarbonyl, ethoxycarbonyl, carboxamido, sulphonamido, carboxy, trifluoromethylthio, trifluoromethoxyl, methylsulphonyl, trifluomethylsulphonyl and methylthio; R 5 is hydrogen or alkyl of 1 to 4 carbon atoms; R 6 is hydrogen or alkyl of 1 to 4 carbon atoms; X is oxygen and the dotted line represents a single or double bond.

Inventors

  • 👤 Derek V. Gardner

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 05:47
CPC Classifications
C; C07; C07D; C07D311/00; C07D311/02; C07D311/04; C07D311/06; C07D311/08; C07D311/16; C07D311/20; C07D311/58

Claims Analysis

Total Claims: 25
Claim 1
Independent Claim 133 words
A compound of the formula (I): ##STR21## or a pharmaceutically acceptable salt thereof wherein the NR 1 R 2 moiety is a 5-, 6-, or 7-membered saturated heterocyclic ring; R 3 is hydrogen, alkyl of 1 to 4 carbon atoms or acyl of 1 to 4 carbon atoms; R 4 is naphthyl or phenyl unsubstituted or substituted by one or two substituents selected from the group consisting of fluorine, chlorine, bromine, methoxyl, benzyloxyl, trifluoromethyl, methyl, cyano, nitro, acetoxyl, amino, methylamino, ethylamino, dimethylamino, diethylamino, acetamido, hydroxyl, methoxycarbonyl, ethoxycarbonyl, carboxamido, sulphonamido, carboxy, trifluoromethylthio, trifluoromethoxyl, methylsulphonyl, trifluoromethylsulphonyl and methylthio; R 5 is hydrogen or alkyl of 1 to 4 carbon atoms; R 6 is hydrogen or alkyl of 1 to 4 carbon atoms; X is oxygen and the dotted line represents a single or double bond.
Claim 2
Dependent Claim 133 words
A compound of the formula (I): ##STR21## or a pharmaceutically acceptable salt thereof wherein the NR 1 R 2 moiety is a 5-, 6-, or 7-membered saturated heterocyclic ring; R 3 is hydrogen, alkyl of 1 to 4 carbon atoms or acyl of 1 to 4 carbon atoms; R 4 is naphthyl or phenyl unsubstituted or substituted by one or two substituents selected from the group consisting of fluorine, chlorine, bromine, methoxyl, benzyloxyl, trifluoromethyl, methyl, cyano, nitro, acetoxyl, amino, methylamino, ethylamino, dimethylamino, diethylamino, acetamido, hydroxyl, methoxycarbonyl, ethoxycarbonyl, carboxamido, sulphonamido, carboxy, trifluoromethylthio, trifluoromethoxyl, methylsulphonyl, trifluoromethylsulphonyl and methylthio; R 5 is hydrogen or alkyl of 1 to 4 carbon atoms; R 6 is hydrogen or alkyl of 1 to 4 carbon atoms; X is oxygen and the dotted line represents a single or double bond.
Claim 3
Dependent Claim 21 words
A compound according to claim 1 wherein the NR 1 R 2 moiety forms a piperidino, morpholino, pyrrolidino or piperazino ring.
Claim 4
Dependent Claim 14 words
A compound according to claim 1 wherein the dotted line represents a single bond.
Claim 5
Dependent Claim 24 words
A compound according to claim 1 wherein R 3 is hydrogen, R 4 is naphthyl and R 5 and R 6 are each methyl.
Claim 6
Dependent Claim 11 words
A compound according to claim 1 wherein R 3 is hydrogen.
Claim 7
Dependent Claim 25 words
A compound according to claim 1 wherein R 4 is phenyl, naphthyl or phenyl substituted by fluorine, chlorine, bromine, methoxyl, benzyloxyl, trifluormethyl, methyl or nitro.
Claim 8
Dependent Claim 15 words
A compound according to claim 1 wherein R 5 and R 6 are each methyl.
Claim 9
Dependent Claim 86 words
A compound according to claim 1 of the formula (II): ##STR22## or a pharmaceutically acceptable salt thereof, wherein R 8 is linked to R 7 so that the moiety NR 7 R 8 forms a 5- or 6- membered saturated heterocyclic ring; R 9 is hydrogen or acetyl; and R 10 is phenyl, naphthyl, or phenyl substituted by fluorine, chlorine, bromine, methoxyl, benzyloxyl, trifluoromethyl, methyl, cyano, nitro, acetoxyl, amino, methylamino, ethylamino, dimethylamino, diethylamino, acetamido, hydroxyl, methoxycarbonyl, ethoxycarbonyl, carboxamido, sulphonamido, carboxy, trifluoromethylthio, trifluoromethoxyl, methylsulphonyl, trifluoromethylsulphonyl or methylthio.
Claim 10
Dependent Claim 30 words
A compound according to claim 8 wherein R 8 is linked to R 7 so that the moiety NR 7 R 8 forms a piperidino, morpholino, pyrrolidino or piperazino ring.
Claim 11
Dependent Claim 11 words
A compound according to claim 8 wherein R 9 is hydrogen.
Claim 12
Dependent Claim 25 words
A compound according to claim 8 wherein R 10 is phenyl, 2-naphthyl, or phenyl substituted by fluorine, chlorine, bromine, methyl, methoxy, hydroxy, trifluoromethyl or nitro.
Claim 13
Dependent Claim 37 words
A compound according to claim 1 of the formula (III): ##STR23## or a pharmaceutically acceptable salt thereof, wherein R 11 is hydrogen, fluorine, chlorine, bromine, methyl, methoxy, or trifluoromethyl and Z is morpholino, piperidino, pyrrolidino or N-methylpiperazino.
Claim 14
Dependent Claim 17 words
A compound according to claim 12 wherein R 11 is hydrogen, fluorine, chlorine, methyl, methoxy or trifluoromethyl.
Claim 15
Dependent Claim 11 words
A compound according to claim 12 wherein R 11 is trifluoromethyl.
Claim 16
Dependent Claim 11 words
A compound according to claim 14 wherein R 11 is 3-trifluoromethyl.
Claim 17
Dependent Claim 11 words
A compound according to claim 12 wherein R 11 is hydrogen.
Claim 18
Dependent Claim 21 words
A compound according to claim 1 of the formula (IV) or (V): ##STR24## wherein Z is morpholino, piperidino, pyrrolidino or N-methylpiperazino.
Claim 19
Dependent Claim 17 words
The compound according to claim 1 which is 7-[2-hydroxy-3-(1-piperidino)propoxy]-2,2-dimethyl-4-phenylchroman or a pharmaceutically acceptable acid addition salt thereof.
Claim 20
Dependent Claim 17 words
The compound according to claim 1 which is 7-[2-hydroxy-3-(1-morpholino)propoxy]-2,2-dimethyl-4-phenylchroman or a pharmaceutically acceptable acid addition salt thereof.
Claim 21
Dependent Claim 17 words
The compound according to claim 1 which is 7-[2-hydroxy-3(1-pyrrolidino)propoxy]-2,2-dimethyl-4-phenylchroman or a pharmaceutically acceptable acid addition salt thereof.
Claim 22
Dependent Claim 17 words
The compound according to claim 1 which is 7-[2-hydroxy-3-(4-methyl-1-piperazino)propoxy]-2,2-dimethyl-4-phenylchroman or a pharmaceutically acceptable acid addition salt thereof.
Claim 23
Dependent Claim 16 words
A compound according to claim 14 in the form of a pharmaceutically acceptable acid addition salt.
Claim 24
Dependent Claim 116 words
A compound selected from the group consisting of a chroman derivative of the formula: ##STR25## and the pharmaceutically acceptable salts thereof wherein R 3 is hydrogen, alkyl of 1 to 4 carbon atoms or acyl of 1 to 4 carbon atoms; R 4 is naphthyl or phenyl unsubstituted or substituted with one or two members selected from the group consisting of fluoro, chloro, bromo, methoxy, benzyloxy, trifluoromethyl, methyl, cyano, nitro, acetoxy, amino, methylamino, ethylamino, dimethylamino, diethylamino, acetamido, hydroxy, carbomethoxy, carbethoxy, carboxamido, sulphonamido, carboxy, trifluoromethylthio, trifluoromethoxy, methylsulphonyl, trifluoromethylsulphonyl and methylthio; each of R 5 and R 6 is hydrogen or alkyl of 1 to 4 carbon atoms; and the dotted line is a single or double bond.
Claim 25
Dependent Claim 116 words
A compound selected from the group consisting of a chroman derivative of the formula: ##STR25## and the pharmaceutically acceptable salts thereof wherein R 3 is hydrogen, alkyl of 1 to 4 carbon atoms or acyl of 1 to 4 carbon atoms; R 4 is naphthyl or phenyl unsubstituted or substituted with one or two members selected from the group consisting of fluoro, chloro, bromo, methoxy, benzyloxy, trifluoromethyl, methyl, cyano, nitro, acetoxy, amino, methylamino, ethylamino, dimethylamino, diethylamino, acetamido, hydroxy, carbomethoxy, carbethoxy, carboxamido, sulphonamido, carboxy, trifluoromethylthio, trifluoromethoxy, methylsulphonyl, trifluoromethylsulphonyl and methylthio; each of R 5 and R 6 is hydrogen or alkyl of 1 to 4 carbon atoms; and the dotted line is a single or double bond.

References Cited (Backward Citations)

US4146539A Cited
US4079066A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-11-18 1984-05-19 1984-11-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-11-18 1988-05-19 1988-11-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-11-18 1992-05-19 1992-11-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag